Denali Therapeutics Inc DNLI
News
Denali Therapeutics Announces Publication in Science Translational Medicine Demonstrating the Potential of the Oligonucleotide Transport Vehicle Platform to Achieve Broad Biodistribution of Antisense Oligonucleotides in the CNS and Muscle Following Intravenous Administration
Biogen boosts profit outlook on 'momentum' for new drugs, but stock dips
Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
Denali Therapeutics Shares Fall After ALS Treatment Misses Primary Endpoint